Skip to main content
. 2022 Jan 13;11(2):378. doi: 10.3390/jcm11020378
ACE-I angiotensin converting enzyme inhibitor
ARB Angiotensin receptor blocker
CHF Congestive heart failure
CKD Chronic kidney disease
CKRT continuous kidney replacement therapy
CI confidence interval
CV cardiovascular
DKA diabetic keto acidosis
DKD diabetic kidney disease
ESKD end stage kidney disease
eGFR estimated glomerular filtration rate
ENaC Epithelial sodium channel
GLP-1 glucagon like peptide-1
HR Hazard ratio
HTN Hypertension
KRT Kidney replacement therapy
MI myocardial infarction
MR mineralocorticoid receptor
MRA mineralocorticoid receptor antagonist
RAAS renin–angiotensin–aldosterone system
SGLT2 sodium-glucose transport protein 2
T2DM type II diabetes mellitus
UACR urine albumin to creatinine ratio